CAS RN: 99010-24-9
1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLINE
Product Availability
Choose a grade to view its available package options.
3 package records0 with current stock2 grade groups
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20251117 |
250mg / 1g |
Out of stock |
5-7 business days | Inquiry |
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250325 |
1g |
Out of stock |
| Inquiry |
| Batchno.20260206 |
250mg |
Out of stock |
| Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 0.25g, 5g, 0.1g
- Available purity: >95%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 99010-24-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 5g |
>95% |
1
In Stock
|
Beijing |
Inquiry |
| 0.1g |
>95% |
0
Out of Stock
|
Shanghai |
Inquiry |
99010-24-9 / 1-(2-methylpropyl)imidazo[4,5-c]quinoline
Standard CAS: 99010-24-9
Multi CAS: Yes
Basic Information
CAS
99010-24-9
Multi CAS
Yes
Molecular Formula
C14H15N3
Molecular Weight
225.290000
Exact Mass
225.126597
InChI
InChI=1S/C14H15N3/c1-10(2)8-17-9-16-13-7-15-12-6-4-3-5-11(12)14(13)17/h3-7,9-10H,8H2,1-2H3
InChIKey
CXYOCSTZCULCAE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
17
Aromatic heavy atom count
13
Fraction Csp3
0.29
Rotatable bonds
2
H-bond acceptors
3
Molar refractivity
69.87
TPSA
30.71
LogP / Solubility
WLOGP
3.24
MLOGP
2.85
XLogP3
3
Consensus LogP
3.03
Log S (ESOL)
-3.71
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.75
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.05
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.79
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5